Research ExplorerPublicationsA Radiation Therapy Oncology Group (RTOG) phase III randomiz...

A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!

Standard

A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now! / Dubben, H H; Beck-Bornholdt, Hans-Peter.

In: INT J RADIAT ONCOL, Vol. 51, No. 2, 2, 2001, p. 563.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Dubben, HH & Beck-Bornholdt, H-P 2001, 'A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!', INT J RADIAT ONCOL, vol. 51, no. 2, 2, pp. 563. <http://www.ncbi.nlm.nih.gov/pubmed/11579925?dopt=Citation>

APA

Dubben, H. H., & Beck-Bornholdt, H-P. (2001). A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now! INT J RADIAT ONCOL, 51(2), 563. [2]. http://www.ncbi.nlm.nih.gov/pubmed/11579925?dopt=Citation

Vancouver

Dubben HH, Beck-Bornholdt H-P. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now! INT J RADIAT ONCOL. 2001;51(2):563. 2.

Bibtex

@article{4700dcda55db4a379741e6314325ee5b,
title = "A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!",
author = "Dubben, {H H} and Hans-Peter Beck-Bornholdt",
year = "2001",
language = "Deutsch",
volume = "51",
pages = "563",
journal = "INT J RADIAT ONCOL",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!

AU - Dubben, H H

AU - Beck-Bornholdt, Hans-Peter

PY - 2001

Y1 - 2001

M3 - SCORING: Zeitschriftenaufsatz

VL - 51

SP - 563

JO - INT J RADIAT ONCOL

JF - INT J RADIAT ONCOL

SN - 0360-3016

IS - 2

M1 - 2

ER -